Manali Garg1, Savneet Kaur2, Arpita Banik1, Vikash Kumar3, Archana Rastogi4, Shiv K Sarin5, Asok Mukhopadhyay3, Nirupma Trehanpati1. 1. Institute of Liver and Biliary Sciences, Department of Molecular and Cellular Medicine, New Delhi, India. 2. Gautam Buddha University, Greater Noida, Uttar Pradesh, India. 3. National Institute of Immunology, New Delhi, India. 4. Institute of Liver and Biliary Sciences, Department of Pathology, New Delhi, India. 5. Institute of Liver and Biliary Sciences, Department of Hepatology, New Delhi, India.
Abstract
OBJECTIVES: Bone marrow derived endothelial progenitor cells (BM-EPCs) are increased in chronic liver disease (CLD). Their role in hepatic fibrosis and regeneration remains an area of intense studies. We investigated the migration and secretory functions of BM-EPCs in fibrotic mice liver. MATERIALS AND METHODS: Bone marrow cells from C57BL6-GFP mice were transplanted into the femur of irradiated C57BL6 mice, followed by CCl4 doses for 8 weeks, to develop hepatic fibrosis (n = 36). Transplanted C57BL6 mice without CCl4 treatment were used as controls. EPCs were analyzed in BM, blood and liver by flow cytometry and immunofluorescence. VEGF and TGF-β were analysed in the hepatic stellate cells (HSCs) and BM-EPCs co-cultures using ELISAs. RESULTS: There was a significant migration of EPCs from BM to blood and to the liver (P ≤ 0.01). Percentage of GFP+ CD31+ EPCs and collagen proportionate area was substantially increased in the liver at 4th week of CCl4 dosage compared to the controls (19.8% vs 1.9%, P ≤ 0.05). Levels of VEGF (533.6 pg/ml) and TGF-β (327.44 pg/ml) also increased significantly, when HSCs were treated with the EPC conditioned medium, as compared to controls (25.66 pg/ml and 5.87 pg/ml, respectively; P ≤ 0.001). CONCLUSIONS: Present findings suggest that BM-EPCs migrate to the liver during CCl4-induced liver injury and contribute to fibrosis.
OBJECTIVES: Bone marrow derived endothelial progenitor cells (BM-EPCs) are increased in chronic liver disease (CLD). Their role in hepatic fibrosis and regeneration remains an area of intense studies. We investigated the migration and secretory functions of BM-EPCs in fibrotic mice liver. MATERIALS AND METHODS: Bone marrow cells from C57BL6-GFP mice were transplanted into the femur of irradiated C57BL6 mice, followed by CCl4 doses for 8 weeks, to develop hepatic fibrosis (n = 36). Transplanted C57BL6 mice without CCl4 treatment were used as controls. EPCs were analyzed in BM, blood and liver by flow cytometry and immunofluorescence. VEGF and TGF-β were analysed in the hepatic stellate cells (HSCs) and BM-EPCs co-cultures using ELISAs. RESULTS: There was a significant migration of EPCs from BM to blood and to the liver (P ≤ 0.01). Percentage of GFP+ CD31+ EPCs and collagen proportionate area was substantially increased in the liver at 4th week of CCl4 dosage compared to the controls (19.8% vs 1.9%, P ≤ 0.05). Levels of VEGF (533.6 pg/ml) and TGF-β (327.44 pg/ml) also increased significantly, when HSCs were treated with the EPC conditioned medium, as compared to controls (25.66 pg/ml and 5.87 pg/ml, respectively; P ≤ 0.001). CONCLUSIONS: Present findings suggest that BM-EPCs migrate to the liver during CCl4-induced liver injury and contribute to fibrosis.
Authors: E Lagasse; H Connors; M Al-Dhalimy; M Reitsma; M Dohse; L Osborne; X Wang; M Finegold; I L Weissman; M Grompe Journal: Nat Med Date: 2000-11 Impact factor: 53.440
Authors: A Kawamoto; H C Gwon; H Iwaguro; J I Yamaguchi; S Uchida; H Masuda; M Silver; H Ma; M Kearney; J M Isner; T Asahara Journal: Circulation Date: 2001-02-06 Impact factor: 29.690
Authors: Bruno Solano de Freitas Souza; Ramon Campos Nascimento; Sheilla Andrade de Oliveira; Juliana Fraga Vasconcelos; Carla Martins Kaneto; Lian Felipe Paiva Pontes de Carvalho; Ricardo Ribeiro-Dos-Santos; Milena Botelho Pereira Soares; Luiz Antonio Rodrigues de Freitas Journal: Cytotherapy Date: 2012-07-19 Impact factor: 5.414
Authors: Savneet Kaur; Rashi Sehgal; Saggere M Shastry; Geoffrey McCaughan; Helen M McGuire; Barbara Fazekas St de Groth; Shiv Sarin; Nirupma Trehanpati; Devanshi Seth Journal: Front Physiol Date: 2018-05-22 Impact factor: 4.566